Dr Mais Hussein
Medical Director Alora HealthThursday, 11 June 2026 - Event Agenda
9:30 AM Panel Discussion | Clinical Innovation | The New Therapeutic Frontier: Pharmacological Breakthroughs Redefining Obesity Care
This session examines how breakthrough GLP-1 receptor agonists and novel combination therapies are transforming obesity treatment paradigms, elevating patient outcomes, reshaping clinical expectations, and establishing obesity as a medically manageable chronic disease requiring long-term pharmaceutical intervention.
Key Takeaways:
• Understanding how advanced GLP-1s and dual/triple agonists achieve superior weight loss and metabolic improvements, including their effects on appetite regulation, insulin sensitivity, and cardiovascular benefits beyond traditional interventions.
• Navigating prescribing guidelines, managing patient expectations for long-term therapy, addressing access and affordability challenges, and integrating pharmacotherapy with lifestyle interventions for optimal sustainable outcomes.
Check out the incredible speaker line-up to see who will be joining Mais.
Download The Latest Agenda
